Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

Bayer image

Bayer cancer drug meets Phase III goal

April 3, 2012 Research and Development, Sales and Marketing Bayer, Cancer, Glivec, Novartis, phase III, regorafenib

Bayer’s stomach cancer pill regorafenib has significantly improved progression free survival in late-stage patients. Results from the Phase III trial …
News

Standardised equipment and centralised spirometry for optimal data quality

April 3, 2012 Research and Development

IntroductionWhen developing the treatments for asthma and COPD, pharmaceutical companies utilise pulmonary function testing (PFT) to determine each compound’s efficacy. …
Feature
Thought Leadership

Considerations with dual site production

April 3, 2012 Research and Development

There are generally two options available when looking to expand storage capacity – build to develop existing facilities or select …
Feature
Thought Leadership

Michael Cola resigns from Shire

April 3, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Michael Cola, Shire

Michael Cola has resigned as the president of Shire Specialty Pharmaceuticals after seven years at the firm.  “On behalf of …
Appointment

Moving Towards a Risk-Based approach to Clinical Trial Management

April 3, 2012 Research and Development

Clinical trials need to be managed to rigorous standards in order to secure the quality and integrity of every aspect …
Feature
Thought Leadership
Roche image

Roche to submit Herceptin successor to regulators

April 2, 2012 Research and Development, Sales and Marketing GSK, Herceptin, Roche, Xeloda

Roche has said it will submit its new breast cancer drug trastuzumab for regulatory review in the US and Europe …
News
michael_holston-1-3001

Merck appoints new chief ethics and compliance officer

March 30, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Bowles, Holston, MSD, Merck

Merck has announced the appointment of Michael Holston as chief ethics and compliance officer. Holston is to succeed Richard Bowles, …
Appointment
a_mahmoud

Inovio appoints ex-Merck vaccines president Dr Adel Mahmoud

March 29, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Inovio, Merck, vaccines

Inovio Pharmaceuticals has announced that Dr Adel Mahmoud has been appointed to its Board of Directors.  Mahmoud, a global infectious …
Appointment

Prostate cancer drug extends life after chemotherapy

March 29, 2012 Research and Development, Sales and Marketing Astellas, Medivation, Zytiga, prostate cancer

Prostate cancer treatment MDV3100 has been shown to extend life by nearly five months in men with advanced disease who …
News
GSK image

GSK settles cancer patent dispute

March 28, 2012 Research and Development, Sales and Marketing GSK, Genmab, Roche, ofatumumab, patents

GlaxoSmithKline has settled a long-running patent dispute over its cancer treatment ofatumumab.  The US patents, which relate to recombinant antibody …
News
Amgen picture

Sanofi sets up cholesterol drug showdown with Amgen

March 27, 2012 Research and Development, Sales and Marketing Amgen, BMS, LDL, Lipitor, Merck, Regeneron, Sanofi

Sanofi and Amgen have posted results for their new injectable cholesterol drugs within 24 hours of each other.  Both drugs …
News

Contract research news in brief

March 27, 2012 Research and Development AMRI, Cetero, Kforce, Particle Sciences and QED Clinical Services, inVentiv Health

Cetero files for bankruptcy after FDA admonishments, AMRI shutters Hungarian facility and inVentiv Health buys Kforce; also updates from Particle …
News

HPI strengthens healthcare and pharma presence with new hire

March 26, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

HPI has strengthened its presence in the healthcare and pharma sectors with the appointment of Marianne MacDonell. She will head …
Appointment

UCB nominates new board members

March 26, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing UCB, board members

UCB has nominated Harriet Edelman and Charles-Antoine Janssen to become new members of UCB’s board of directors. The new nominations …
Appointment

Rare diseases – pharma’s new frontier

March 26, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Big Pharma, CAPS, McConaghie, rare diseases

The last ten years has seen our understanding of rare diseases move ahead rapidly, often thanks to greater understanding of …
Feature
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025